Prior Stephen David
Chief Strategy Officer at ANTX
- Sold, on record
- $10k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jan 6, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ANTXAN2 Therapeutics, Inc.Chief Strategy Officer
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ANTXNo planJan 3, 2025 2025
Sold 2,029 shares at $1.34 ($3k)
Prior Stephen David, Chief Strategy Officer
No 10b5-1 planSold 5.7% of holdings ($47k position)33,313 shares leftFirst sale on recordFiling
- 2 Form 4 sale ANTXNo planNov 4, 2025 +305 days
Sold 765 shares at $1.14 ($872)
Prior Stephen David, Chief Strategy Officer
No 10b5-1 planSold 1.2% of holdings ($76k position)65,548 shares leftFiling
- 3 Form 4 sale ANTXNo planJan 6, 2026 +63 days
Sold 6,462 shares at $1.00 ($6k)
Prior Stephen David, Chief Strategy Officer
No 10b5-1 planSold 9.9% of holdings ($66k position)59,086 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Jan 7, 2026 | ANTX | Chief Strategy Officer | Form 4 sale | 6,462 | $6k | 9.9% | No plan | SEC |
| Nov 4, 2025 | Nov 6, 2025 | ANTX | Chief Strategy Officer | Form 4 sale | 765 | $872 | 1.2% | No plan | SEC |
| Jan 3, 2025 | Jan 7, 2025 | ANTX | Chief Strategy Officer | Form 4 sale | 2,029 | $3k | 5.7% | No plan | SEC |